HKUMed is actively seeking outstanding scholars through its ‘140 for 140 Global Recruitment Campaign’ to address rapid advancements in teaching and research and to expand collaboration with Mainland China and globally. Building on a series of global events over the past two years, Professor Chak-sing Lau, Vice-President & Pro-Vice-Chancellor (Health) and Dean of Medicine, led another delegation to London in May 2025 to attract top talent, particularly in fields like medical research, artificial intelligence and big data. They also visited prestigious institutions, including the University of Oxford, the University of Cambridge, King's College London, the University College London, the University of Bristol and the Francis Crick Institute. Their efforts led to encouraging exchanges and potential partnerships. They also held a gathering with alumni and exchange students, further strengthening connections. The delegation included Professor Ivan Hung Fan-ngai, Associate Dean (Partnership & Engagement); Professor Michael Häusser, Director of the School of Biomedical Sciences and Chair Professor of Neuroscience; and Professor Khuloud T Al-Jamal, Head of the Department of Pharmacology and Pharmacy. 醫學院透過「140 for 140全球人才招聘計劃」，積極廣納優秀學者，以應對教學和科研的迅速發展，並拓展與內地及國際的合作。繼過去 兩年舉辦的連串全球活動，副校長（健康）兼醫學院院長劉澤星教授於今年5月再率團前往倫敦舉辦招聘活動，吸納人才，尤其是在醫學研究、 人工智能與大數據等範疇。代表團還到訪多所頂尖學府，包括牛津大學、劍橋大學、倫敦國王學院、倫敦大學學院、布里斯托大學和 Francis Crick Institute 等，並促成了後續交流和潛在的合作。他們還舉行聚會，聯繫當地校友和交流學生。代表團成員包括副院長（夥伴 拓展及協作）孔繁毅教授、生物醫學學院院長及講座教授Michael Häusser教授及藥理及藥劑學系系主任Khuloud T Al-Jamal教授。 In mid-2025, HKUMed showcased its leadership in healthcare innovation and global collaboration, spearheading initiatives in AI and biotechnology. On 26 May, Dean Professor Chak-sing Lau led a pivotal session titled ‘Unlocking the Potential of AI in Healthcare’ at the Asia Summit on Global Health. Co-organised by the HKSAR Government and the Hong Kong Trade Development Council, the session convened experts in computer science, medical data science and AI, along with representatives from the government and healthcare sectors. The discussion explored AI's transformative impact across medical research, education and healthcare services. Further highlighting HKUMed's expertise, on the following day, Professor Stephanie Ma Kwai-yee, University Associate Vice-President (Research and Innovation) (also with Biomedical Sciences), and Professor Brian Chung Hon-yin (Paediatrics and Adolescent Medicine, SClinMed) addressed cancer evolution and the urgent need for rare diseases treatments. Building on this momentum, HKUMed reinforced Hong Kong's status as a burgeoning biotech hub at BIO 2025 in Boston from 16 to 19 June. HKUMed representatives, including Professor Stephanie Ma Kwai-yee and Professor Joshua Ho Wing-kei, Assistant Dean (Innovation & Technology Transfer), joined a delegation of 16 leading life and health technology companies for the first time, led by Hong Kong Science and Technology Parks Corporation and InvestHK. Significantly, five of the participating companies are affiliated with HKUMed. The Faculty also showcased projects from its Centre for Translational Stem Cell Biology and Centre for Virology, Vaccinology and Therapeutics. This strategic presence amplified HKUMed's innovations on the world stage, attracting enterprise partnerships, talent and investment essential for solidifying Hong Kong's position as a leading global biotech centre. 港大醫學院於2025年中積極參與多項重要活動，彰顯其在醫療創新的領導地位。5月26日，院長劉澤星教授於香港特區政府及香港貿易 發展局合辦的「亞洲醫療健康高峰論壇」上，主持關鍵會議「發掘AI在醫療領域的潛能」，與各方專家深入探討AI如何革新醫學研究、教育 及醫療服務。大學協理副校長（研究及創新）馬桂宜教授（生物醫學學院）及鍾侃言教授（臨床醫學學院兒童及青少年科學系）翌日亦就癌症 演變、罕見疾病治療等發表見解。學院代表包括馬桂宜教授及助理院長（創新及技術轉移）何永基教授，於6月16至19日聯同香港科技園 公司及投資推廣署率領的16家頂尖生命健康科技企業代表團，首赴波士頓參與全球最大型生物科技博覽BIO 2025。參展企業中，五家與 醫學院密切相關。幹細胞轉化研究中心及病毒與疫苗研究中心的多項創新項目同步亮相，充分展示學院科研實力，成功吸引企業、人才及 投資者關注，有助提升香港作為國際領先生物科技中心的地位。 Global Outreach to Recruit Talent, Engage Alumni and Promote Collaboration 全球廣納賢才 滙聚校友 促進合作新機遇 HKUMed Drives Global Health Innovation: AI and Biotech 醫學院推動全球醫療健康：AI及生物科技 18
RkJQdWJsaXNoZXIy Mzg4NDg0